5299 篇
13868 篇
408791 篇
16079 篇
9269 篇
3869 篇
6465 篇
1238 篇
72402 篇
37108 篇
12060 篇
1619 篇
2823 篇
3387 篇
640 篇
1229 篇
1965 篇
4868 篇
3821 篇
5293 篇
全球性勃起功能障碍药物市场报告(2014-2018年)
Global Erectile Dysfunction Drugs Market 2014-2018
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Treatment
08. Market Assessment of Top Drugs
08.1 Viagra
08.1.1 Historic Sales
08.2 Cialis
08.2.1 Historic Sales
08.3 Levitra
08.3.1 Historic Sales
09. Competitive Assessment of Top Drugs
10. Geographical Segmentation
11. Rate of Incidence and Prevalence
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Apricus Biosciences
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Geographical Segmentation by Revenue 2013
20.1.4 Business Strategy
20.1.5 Recent Information
20.1.6 SWOT Analysis
20.2 Bayer
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Business Segmentation
20.2.4 Business Segmentation by Revenue 2012 and 2013
20.2.5 Geographical Segmentation by Revenue
20.2.6 Business Strategy
20.2.7 Key Information
20.2.8 SWOT Analysis
20.3 Dong-A Socio
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation
20.3.4 Geographical Segmentation by Revenue 2013
20.3.5 Business Strategy
20.3.6 Recent Information
20.3.7 SWOT Analysis
20.4 Eli Lilly
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation by Revenue 2013
20.4.4 Business Segmentation by Revenue 2012 and 2013
20.4.5 Geographical Segmentation by Revenue
20.4.6 Business Strategy
20.4.7 Key Information
20.4.8 SWOT Analysis
20.5 Pfizer
20.5.1 Key Facts
20.5.2 Business Description
20.5.3 Business Segmentation
20.5.4 Business Segmentation by Revenue 2013
20.5.5 Business Segmentation by Revenue 2012 and 2013
20.5.6 Geographical Segmentation by Revenue
20.5.7 Business Strategy
20.5.8 Key Information
20.5.9 SWOT Analysis
20.6 Vivus
20.6.1 Key Facts
20.6.2 Business Overview
20.6.3 Business Segmentation by Revenue 2013
20.6.4 Business Segmentation by Revenue 2012 and 2013
20.6.5 Geographical Segmentation by Revenue 2013
20.6.6 Business Strategy
20.6.7 Recent Information
20.6.8 SWOT Analysis
21. Other Reports in this Series